The price of Neogenomics Inc. (NASDAQ: NEO) closed at $13.85 in the last session, up 0.73% from day before closing price of $13.75. On the day, 632916 shares were traded.
Ratios:
We take a closer look at NEO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.95 and its Current Ratio is at 6.20. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.64.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 29, 2023, Reiterated its Buy rating but revised its target price to $21 from $25 previously.
On August 21, 2023, Stephens Upgraded its rating to Overweight which previously was Equal-Weight but kept the price unchanged to $18.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 04 ’24 when TETRAULT LYNN A. sold 6,112 shares for $15.97 per share. The transaction valued at 97,579 led to the insider holds 50,062 shares of the business.
Olivo Alicia C sold 2,587 shares of NEO for $38,713 on Feb 15 ’24. The General Counsel now owns 34,866 shares after completing the transaction at $14.96 per share. On Nov 17 ’23, another insider, Olivo Alicia C, who serves as the General Counsel of the company, sold 2,669 shares for $18.39 each. As a result, the insider received 49,083 and left with 37,140 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 2.99 while its Price-to-Book (P/B) ratio in mrq is 1.87.
Stock Price History:
Over the past 52 weeks, NEO has reached a high of $21.22, while it has fallen to a 52-week low of $11.03.
Shares Statistics:
A total of 127.37M shares are outstanding, with a floating share count of 126.18M. Insiders hold about 1.16% of the company’s shares, while institutions hold 99.20% stake in the company.
Earnings Estimates
The company has NIO Inc. analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $38.11, with high estimates of $61.70 and low estimates of $123.45.
Analysts are recommending an EPS of between $Utilities and $Healthcare for the fiscal current year, implying an average EPS of $Basic Materials.
